Inflitza 25mg Capsule
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Midostaurin (25mg)
Overview Inflitza 25mg Capsule
Leukemia treatment with Mylanza 25mg capsules targets acute myeloid leukemia by inhibiting cancerous cell proliferation, thus controlling disease progression. Optimal absorption and minimized nausea/vomiting occur when taken with food. Dosage and frequency are determined by your physician based on individual needs and may adjust over time; strictly adhere to prescribed instructions to prevent severe adverse reactions. Therapeutic effects might not be immediately apparent; discontinue only under medical guidance. Common side effects include nausea, vomiting, headache, muscle/joint pain, epistaxis, high blood sugar, and upper respiratory infections. Mylanza 25mg can lower blood cell counts, increasing infection risk, necessitating regular blood tests to monitor blood cell counts, cardiac function, liver health, and uric acid levels. Avoid activities requiring alertness if dizziness occurs. Inform your physician of all pre-existing conditions and current medications, including those for infections, as drug interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Uses of Inflitza 25mg Capsule
Managing Acute Myeloid Leukemia (AML)
Major Benefits of Inflitza 25mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest Inflitza 25mg Capsules with a meal.
Common Side effects of Inflitza 25mg Capsule:
- Febrile neutropenia
- Nausea
- Mucositis
- Vomiting
- Headache
- Petechiae (red or purple spot caused by bleeding into the skin)
- Musculoskeletal (bone, muscle or joint) pain
- Nosebleeds
- Infection
- Increased glucose level in blood
- Upper respiratory tract infection
How to use Inflitza 25mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Inflitza 25mg Capsules with food.
How Inflitza 25mg Capsule works:
Inflitza 25mg capsules inhibit the activity of a rogue protein responsible for cancer cell proliferation, thereby curbing the growth and spread of malignant and mast cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inflitza 25mg Capsules may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Inflitza 25mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Inflitza 25mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Inflitza 25mg Capsules is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Inflitza 25mg capsules appear to pose minimal risk for individuals with kidney impairment. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
Inflitza 25mg capsules appear to pose minimal risk for individuals with hepatic impairment. Existing evidence indicates dose modification may be unnecessary, though further investigation is warranted. Physician consultation is recommended.
What if you forget to take Inflitza 25mg Capsule :
NA
Facts to Know About Inflitza 25mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Indole carbazoles |
| Developing Habits | No. |
| Actions | Drugs that block protein production |
3,018 People bought this recently